Latest News
- No Transactions Without Biometrics
- Passenger Caught With Pure Cocaine From Europe
- The Elderly Man Was Not Insulted By Me
- 97% Of MEW Workforce Are Kuwaitis; Strength 34,417
- Rushing Home For 'iftar' Causes Accidents And Deaths
- Expect Hot Days, Cool Nights, And Thunderstorms In Kuwait
- Health Procedures For Expatriates Updated
- Kuwait's Agility Global Seeks Inclusion On Abu Dhabi's ADX
- Public Authority For Industry Completes Industry Law Amendment P...
- Indian Ambassador Hosts Ramadan Celebration In Kuwait
- Al-Mashaan Grants Authority For Transfers Of Municipal Departmen...
- For The Expansion Of The Subiya Site, 204.178 Million Dinars And...
Covaxin Effective Against Variants First Found In India And Uk, Says Bharat Biotech
Bharat Biotech on Sunday announced that its coronavirus vaccine Covaxin is effective against the mutant strains of the virus, including the ones first detected in the United Kingdom and India.
“Covaxin gets international recognition yet again, by scientific research data published demonstrating protection against the new variants,” the company’s Joint Managing Director Suchitra Ella said in a tweet.
A study published on May 7 in Clinical Infectious Diseases, a peer-reviewed medical journal published by Oxford University Press, shows that the vaccine neutralises “all key emerging variants tested”, including the B.1.617, first detected in India and the B.1.1.7, found first in the UK. Both the strains have been classified as “variants of concern” by the World Health Organization.
In another tweet, Ella said that while a modest reduction in neutralisation was found in case of the B.1.617, the “neutralizing titre levels” remained above levels expected to be protective.
Last month, the Indian Council of Medical Research, which had collaborated in the development of Covaxin, had also made similar claims about the vaccine. However, a day later, Bharat Biotech Chairperson Krishna Ella he had “did not have knowledge” on the matter.
Preliminary results of a study conducted by the Centre for Cellular and Molecular Biology had shown last month that Serum Institute of India’s Covishield vaccine also gave protection against the B.1.617 variant.
Sunday’s development on Covaxin may give more reason for other companies to start manufacturing the Bharat Biotech vaccine. On Thursday, the Centre had said that Bharat Biotech was willing to invite other companies to produce its vaccine. The Centre also said that it will provide all possible assistance to companies willing to manufacture the vaccine to ramp up its supply.
SOURCE : TIMES KUWAIT
Trending News
-
MoI Urges Biometric Fingerprinting Compliance Ahea...
21 March 2024
-
5 Days Holiday For Eid Al-Fitr Begins On April 9th
25 March 2024
-
Over 120,000 Expat Offenders Will Benefit From Kuw...
14 March 2024
-
Kuwait Offering Amnesty To Illegal Expats
17 March 2024
-
From April 1 To July 1, Kuwait Grants Amnesty To V...
14 March 2024
-
Kuwaiti Banks Elevate Non-Resident Credit To 4.17...
18 March 2024
-
Central Bank Of Kuwait Provides Banks With New Ba...
20 March 2024
-
Banks In Kuwait Report Robust Profits Despite The...
21 March 2024
-
Kuwait's Clean Energy Journey: Progress And Challe...
23 March 2024
-
Driving Licenses With Smart Technology
25 March 2024
Comments Post Comment